-
Eli Lilly’s COVID-19 therapies to enter clinical trials
europeanpharmaceuticalreview
April 17, 2020
The enterprise announced its drug OLUMIANT® (baricitinib) and an investigational antibody will enter clinical trials in US COVID-19 patients later this month.
-
Are companies optimistic about growth prospects following COVID-19 stimulus measures?
pharmaceutical-technology
April 17, 2020
The COVID-19 outbreak has marred the growth expectations of companies of all sizes globally, across multiple industries.
-
Fujifilm boosts production capacity for potential Covid-19 drug Avigan
pharmaceutical-technology
April 17, 2020
Japan’s Fujifilm has expanded manufacturing capacity to boost production of its influenza drug Avigan (favipiravir), being assessed to potentially treat Covid-19.
-
High concern over the spread of COVID-19 continues: Poll
pharmaceutical-technology
April 17, 2020
Concerns over the spread of coronavirus have increased as more countries announced COVID-19 cases in March.
-
Octapharma Supports New COVID-19 Trial
contractpharma
April 17, 2020
Aims to assess if Intravenous Immunoglobulin (IVIG) can halt coronavirus progression to respiratory failure.
-
HALIX and University of Oxford collaborate for GMP manufacturing of COVID-19 Vaccine
expresspharma
April 17, 2020
The nCoV-19 vaccine is based on the Jenner Institute’s adenovirus vaccine vector (ChAdOx1) technology, which was chosen as the most suitable candidate for a SARS-CoV-2 (COVID-19) vaccine.
-
BMGF Expands COVID-19 Commitment to more than $250 million
expresspharma
April 17, 2020
New funding will help life sciences companies secure financing to develop diagnostics, therapeutics, and vaccines for COVID-19.
-
ACG continues production to meet mission-critical pharmaceutical requirements in tackling COVID-19, with employee safety a top priority across its operations
expresspharma
April 17, 2020
Despite widespread disruption, ACG is continuing production in its factories across the world, and helping to keep supply chains running smoothly to meet mission-critical demands.
-
NCOA Teams with Airbnb to Address Social Isolation among Older Adults
prnewswire
April 16, 2020
The National Council on Aging (NCOA) is partnering with Airbnb to address COVID-19 related social isolation by providing homebound older adults with a new way to connect with others and travel virtually during the pandemic.
-
Roivant Doses First Patient in Pivotal BREATHE Clinical Trial Evaluating Gimsilumab in COVID-19 Patients for the Prevention and Treatment of Acute Respiratory Distress Syndrome
prnewswire
April 16, 2020
Roivant Sciences announced that the first patient was dosed at Temple University Hospital in Philadelphia in an adaptive, randomized, double-blind, placebo-controlled ...